Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
- A. CammP. Kirchhof I. Zupan
- 1 October 2010
Medicine
Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient…
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- J. McMurrayS. Adamopoulos P. Ponikowski
- 1 August 2012
Medicine
Turk Kardiyoloji Dernegi arsivi : Turk…
Authors/Task Force Members: John J. McMurray (Chairperson) (UK), Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Angelo Auricchio (Switzerland), Michael Bohm ( Germany), Kenneth Dickstein (Norway), Volkmar Falk (Sw Switzerland), Gerasimos Filippatos (G Greece), Cândida Fonseca (Portugal), Miguel Angel Gomez-Sanchez (Spain).
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
- J. SteffelP. Verhamme W. Shimizu
- 21 April 2018
Medicine
Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with atrial fibrillation (AF) and have emerged as the preferred choice, particularly in patients newly started on antICOagulation.
ESC Guidelines on the management of cardiovascular diseases during pregnancy
- V. Regitz-ZagrosekC. B. Lundqvist C. Warnes
- 2011
Medicine
Authors/Task Force Members Vera Regitz-Zagrosek (Chairperson) (Germany)*, Carina Blomstrom Lundqvist (Sweden), Claudio Borghi (Italy), Renata Cifkova (Czech Republic), Rafael Ferreira (Portugal),…
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
- J. OlesenG. Lip C. Torp-Pedersen
- 15 August 2012
Medicine
Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding.
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
- J. OlesenG. Lip C. Torp-Pedersen
- 31 January 2011
Medicine
CHA2DS2-VASc performed better than CHADS2 in predicting patients at high risk, and those categorised as low risk by CHA2 DS2- VASc were truly at low risk for thromboembolism.
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.
- M. GliksonR. Wolff B. Meier
- 1 January 2020
Medicine
The EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update is an update.
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
- C. T. PedersenG. Kay I. Savelieva
- 1 October 2014
Medicine
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot…
- G. LipC. Laroche A. Maggioni
- 1 March 2014
Medicine
The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries.
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- J. OlesenG. Lip C. Torp-Pedersen
- 20 July 2011
Medicine
This large cohort study confirms the efficacy of VKA and no effect of ASA treatment on the risk of stroke/thromboembolism in patients with non-valvular atrial fibrillation in Denmark.
...
...